6avn
From Proteopedia
(Difference between revisions)
m (Protected "6avn" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of unbound anti-HIV antibody Fab PGV19 at 2.5 A== | |
+ | <StructureSection load='6avn' size='340' side='right' caption='[[6avn]], [[Resolution|resolution]] 2.50Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[6avn]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6AVN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6AVN FirstGlance]. <br> | ||
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1PE:PENTAETHYLENE+GLYCOL'>1PE</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6avn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6avn OCA], [http://pdbe.org/6avn PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6avn RCSB], [http://www.ebi.ac.uk/pdbsum/6avn PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6avn ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Furin cleavage of the HIV envelope glycoprotein is an essential step for cell entry that enables formation of well-folded, native-like glycosylated trimers, releases constraints on the fusion peptide, and limits enzymatic processing of the N-glycan shield. Here, we show that a cleavage-independent, stabilized, soluble Env trimer mimic (BG505 NFL.664) exhibits a "closed-form", native-like, prefusion conformation akin to furin-cleaved Env trimers. The crystal structure of BG505 NFL.664 at 3.39 A resolution with two potent bNAbs also identifies the full epitopes of PGV19 and PGT122 that target the receptor binding site and N332 supersite, respectively. Quantitative site-specific analysis of the glycan shield reveals that native-like glycan processing is maintained despite furin-independent maturation in the secretory pathway. Thus, cleavage-independent NFL Env trimers exhibit quaternary protein and carbohydrate structures similar to the native viral spike that further validate their potential as vaccine immunogen candidates. | ||
- | + | Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer.,Sarkar A, Bale S, Behrens AJ, Kumar S, Sharma SK, de Val N, Pallesen J, Irimia A, Diwanji DC, Stanfield RL, Ward AB, Crispin M, Wyatt RT, Wilson IA Nat Commun. 2018 May 16;9(1):1956. doi: 10.1038/s41467-018-04272-y. PMID:29769533<ref>PMID:29769533</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | [[Category: | + | </div> |
+ | <div class="pdbe-citations 6avn" style="background-color:#fffaf0;"></div> | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Sarkar, A]] | ||
+ | [[Category: Wilson, I A]] | ||
+ | [[Category: Anti-hiv neutralizing antibody]] | ||
+ | [[Category: Cd4 binding site epitope]] | ||
+ | [[Category: Immune system]] | ||
+ | [[Category: Vrc01-class lambda antibody]] |
Revision as of 05:33, 27 June 2018
Crystal structure of unbound anti-HIV antibody Fab PGV19 at 2.5 A
|